Beta-hCG,Quantitative (Tumor Marker),CSF CSF-HCG TM

Synonyms

Allscripts (AEHR) Order Name

Beta-hCG, Quantitative (Tumor Marker), CSF

Sunrise Clinical Manager (SCM) Order Name

Beta-hCG, Quantitative (Tumor Marker), CSF

EPIC Order Name

CSF, Beta-hCG, Quantitative (Tumor Marker)

Clinical Info

Human chorionic gonadotropin (hCG) is a valuable aid in the management of patients with trophoblastic tumors, nonseminomatous testicular tumors,
and seminomas when used in conjunction with information available from the clinical evaluation and other diagnostic procedures. 
Increased hCG concentrations have also been observed in melanoma, carcinomas of the breast, gastrointestinal tract, lung, and ovaries, 
and in benign conditions including cirrhosis, duodenal ulcer, and inflammatory bowel disease. The result cannot be interpreted as absolute 
evidence of the presence or absence of malignant disease. The result is not interpretable as a tumor marker in pregnant females.

Specimen Type

CSF

Specimen Volume

0.5 mL CSF in Standard Transport Tube. (Min: 0.3 mL)

Container

0.5 mL CSF in Standard Transport Tube. (Min: 0.3 mL)

Collection Instructions

Container: CSF in Standard Plastic Transport Tube
Specimen Volume: 0.5 mL (Min Volume: 0.3 mL)

Transport Instructions

Refrigerated Temperature

Specimen Stability

Room Temperature: 5 days
Refrigerated: 2 weeks
Frozen: 1 year

Methodology

Quantitative Electrochemiluminescent Immunoassay

Days Performed

TAT: 2-3 Days

Performing Laboratories

ARUP Laboratories

CPT

84702

PDM

255568, 255568, BHCGCSF

Result Interpretation

Forms